payment delays intended to minimize the Company’s economic loss and to avoid foreclosure or repossession of
collateral.
Three months ended September 30, 2024. During the three months ended September 30, 2024, the Company entered into
9 loan modifications with an aggregate carrying value of $224.4 million, or 2.5% of total loans, net. These modified
loans include a combination of changes to the contractual terms which were in the form of term extensions, other-than-
insignificant payment delays, and interest reductions.
There was 1 loan with a carrying value of $93.3 million, or 1.0% of loans, net, that was modified to include an interest
payment deferral of 7 months and includes payments for periods before the modification date. There were 7 loans with
an aggregate carrying value of $68.8 million, or 0.8% of loans, net that were modified to include both term extensions
and interest payment deferrals. The term extensions ranged between 2 and 125 months with a weighted average of 11
months added to the original loan term. Included within these modifications was 1 SBA loan with a carrying value of
less than $0.1 million with a 125 month term extension, which is included in the range mentioned above. Interest
payment deferrals ranged between 6 and 28 months with a weighted average of 15 months and include payments for
periods before the modification date. Payment modifications include the reduction of interest payments to equal excess
net operating income with the difference between the original rate and the interest collected due at maturity. In most
cases, cash management accounts are set up for the loans and default interest is waived. There was 1 loan with a carrying
value of $62.3 million, or 0.7% of loans, net that was modified to include an 18 month term extension, a 22 month
interest payment deferral and an interest rate reduction from SOFR + 3.30% to SOFR + 0.50% from October 2024 to
August 2025 and to SOFR + 1.00% from September 2025 to August 2026.
Of the loans that were modified during the three months ended September 30, 2024, substantially all were on accrual
status. During the three months ended September 30, 2024, $2.5 million of total capital was invested by the borrowers,
substantially all in the form of payments in contribution to interest reserve accounts.
Nine months ended September 30, 2024. During the nine months ended September 30, 2024, the Company entered into
32 loan modifications with an aggregate carrying value of $772.3 million, or 8.5% of total loans, net. These modified
loans include a combination of changes to the contractual terms which were in the form of term extensions, other-than-
insignificant payment delays, and interest reductions.
There were 20 loans with an aggregate carrying value of $425.6 million, or 4.7% of loans, net, that were modified to
include both term extensions and interest payment deferrals. The term extensions ranged between 2 and 125 months with
a weighted average of 12 months added to the original loan term. Included within these modifications was 1 SBA loan
with a carrying value of less than $0.1 million with a 125 month term extension, which is included in the range
mentioned above. Interest payment deferrals ranged between 6 and 32 months with a weighted average of 14 months and
include payments for periods before the modification date. Payment modifications include the reduction of interest
payments to equal excess net operating income with the difference between the original rate and the interest collected
due at maturity. In most cases, cash management accounts are set up for the loans and default interest is waived. There
were 4 loans with a carrying value of $151.8 million, or 1.7% of loans, net that were modified to include interest
payments deferrals which ranged between 7 and 28 months with a weighted average of 11 months and include payments
for periods before the modification date. Payment modifications include the reduction of interest payments to equal
excess net operating income with the difference between the original rate and the interest collected due at maturity. In
most cases, cash management accounts are set up for the loans and default interest is waived. There was 1 loan with a
carrying value of $74.3 million, or 0.8% of loans, net that was modified to include both an 18 month term extension
added to the original loan term and an interest rate reduction from SOFR + 3.25% to a fixed rate of 6.0% from June 2024
to December 2024 and 6.5% from January 2025 to July 2025. There was 1 loan with a carrying value of $62.3 million, or
0.7% of loans, net that was modified to include an 18 month term extension added to the original loan term, a 22 month
interest payment deferral, and an interest rate reduction from SOFR + 3.30% to SOFR + 0.50% from October 2024 to
August 2025 and to SOFR + 1.00% from September 2025 to August 2026. There were 6 loans with an aggregate
carrying value of $58.3 million, or 0.6% of loans, net that were modified to include term extensions which ranged
between 10 and 24 months with a weighted average of 17 months added to the original loan term.
Of the loans that were modified during the nine months ended September 30, 2024, substantially all were on accrual
status. During the nine months ended September 30, 2024, $9.7 million of total capital was invested by the borrowers,
substantially all in the form of payment towards past due interest, principal or contribution to various reserve accounts.
Three months ended September 30, 2023. During the three months ended September 30, 2023, the Company entered into
5 loan modifications with an aggregate carrying value of $3.3 million, or less than 0.1% of total loans, net. These